
First Clinical Trial Authorised in Germany for a Peptide Vaccine against COVID-19
On 25 November 2020, the Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, authorised the first phase 1 clinical trial of a peptide vaccine against COVID-19 […]